(IN BRIEF) Novartis has finalized its US manufacturing and research expansion plan with the announcement of a seventh new facility in Morrisville, North Carolina, dedicated to producing active pharmaceutical ingredients for solid-dose medicines and RNA therapies. The move is part … Read the full press release →
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Switzerland, Technology
Tagged API production, biotechnology, Carlsbad California, Denton Texas, drug development, Healthcare Innovation, Indianapolis Indiana, Millburn New Jersey, Morrisville, North Carolina, Novartis, Novartis Finalizes $23 Billion US Expansion Program Enhancing Domestic Manufacturing and Research Infrastructure, Novartis Strengthens US Production Network with New Facility Supporting Advanced Therapies and Supply Chain Resilience, pharmaceutical manufacturing, radioligand therapy, RNA therapeutics, San Diego research center, supply chain resilience, US expansion, Vas Narasimhan, Winter Park Florida
(IN BRIEF) Novartis has announced that its Phase III PSMAddition trial of Pluvicto™ in combination with standard of care (SoC) has met its primary endpoint, showing a significant benefit in radiographic progression-free survival (rPFS) and a positive trend in overall … Read the full press release →
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged androgen receptor pathway inhibitors, cancer research, clinical trials, FDA approval, FDA regulatory review, metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer, mHSPC, Novartis, Novartis oncology, overall survival, Phase III PSMAddition, Pluvicto, progression-free survival, prostate cancer, prostate cancer treatment, PSMA-positive, radioligand therapy, treatment options
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
